Richard W Pascoe
CIK 1343266 · Chief Executive Officer · last filed 2024-01-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$375.3K
Companies
7
Total Filings
65
Lifetime Open-Market Net
-$703.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SEELOS THERAPEUTICS, INC. (SEEL) Delisted | Director | 40 | $0.39 | $16 | $0 | 7 | 2024-01-08 |
| ZVRA | Chief Executive Officer | 29,973 | $12.52 | $375.3K | $42.0K | 1 | 2023-03-13 |
| ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Chief Executive Officer | 19,973 | $5.81 | $116.0K | $94.5K | 16 | 2023-01-13 |
| Histogen Inc. (HSTO) Delisted | President, CEO & Director | 1,500 | $0.21 | $322 | $35.2K | 4 | 2021-03-30 |
| SEELOS THERAPEUTICS, INC. (APRI) Delisted | CEO & Secretary | 6,674 | — | — | $128.1K | 14 | 2018-11-30 |
| Pernix Sleep, Inc. (SOMX) Delisted | President and CEO | 104,927 | — | — | -$1.00M | 19 | 2013-01-03 |
| ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Senior VP, COO | — | — | — | $0 | 3 | 2008-04-15 |
Recent Filings · Page 2 of 7
65 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-21 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-30 | Histogen Inc. (HSTO) Delisted | Buy (P) | +20,000 | $22.8K | EDGAR |
| 2021-01-15 | Histogen Inc. (HSTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-08 | SEELOS THERAPEUTICS, INC. (SEEL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-07 | Histogen Inc. (HSTO) Delisted | Buy (P) | +10,000 | $12.4K | EDGAR |
| 2020-08-18 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Buy (P) | +10,000 | $6.4K | EDGAR |
| 2020-06-22 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-28 | Histogen Inc. (HSTO) Delisted | Other (J) | — | $0 | EDGAR |
| 2020-01-07 | SEELOS THERAPEUTICS, INC. (SEEL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-07-02 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Grant (A) | +8,928 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.